Taking into account the Authority’s conclusions, it is appropriate to allow the placing on the market of infant and follow-on formula manufactured from the specific protein hydrolysate as described in the opinion. Therefore, the requirements for protein hydrolysates set out in Regulation (EU) 2016/127 should be updated and adapted to also include the requirements for the specific protein hydrolysate as described in the opinion.
Recital 5, Regulation (EU) 2024/2684
In forcesince 2 Feb 2024